BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/16/2025 3:11:48 AM | Browse: 18 | Download: 0
Category |
Oncology |
Manuscript Type |
Editorial |
Article Title |
Unraveling the role of flotillin-1 in driving hepatocellular carcinoma progression through transcription factor E3-mediated Golgi stress response
|
Manuscript Source |
Invited Manuscript |
All Author List |
Chiara Mazziotta and John Charles Rotondo |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Italian Association for Cancer Research (AIRC) |
21956 |
Italian Ministry of Health - 5 × 1000 funds 2023 |
|
|
Corresponding Author |
Chiara Mazziotta, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, United States. chiara_mazziotta@dfci.harvard.edu |
Key Words |
Hepatocellular carcinoma; Transcription factor E3; Flotillin-1; Mechanistic target of rapamycin complexes 1 and 2; Golgi stress |
Core Tip |
Hepatocellular carcinoma (HCC) is currently considered a primary contributor of cancer-associated mortality on a global scale. The authors elucidate a novel mechanism whereby the lipid raft protein flotillin-1 (FLOT1) drives HCC progression through transcription factor E3-mediated Golgi stress response. FLOT1 overexpression enhanced proliferation, migration, invasion, and suppressed apoptosis in vitro and in mice, whereas gene silencing reversed these phenotypes. Mechanistically, FLOT1 inhibits mechanistic target of rapamycin complexes 1 and 2 via ubiquitination, promoting transcription factor E3 dephosphorylation and subsequent nuclear translocation, resulting in enhanced expression of multiple genes involved in Golgi stress response. These findings advance our understanding of lipid raft-associated proteins in cancer and propose FLOT1 as a potential target for the treatment of HCC. |
Citation |
Mazziotta C, Rotondo JC. Unraveling the role of flotillin-1 in driving hepatocellular carcinoma progression through transcription factor E3-mediated Golgi stress response. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-07-28 14:23 |
 |
Peer-Review Started |
|
2025-07-28 14:23 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-08-01 10:09 |
 |
Revised |
|
2025-08-12 19:23 |
 |
Second Decision |
|
2025-09-16 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-09-16 03:11 |
 |
Articles in Press |
|
2025-09-16 03:11 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345